真實世界資料(RWD) 市場：按組件、按應用、按最終用戶、按地區

全球真實世界資料（RWD）市場規模預計將從2023年的15.9億美元成長到2030年的40.7億美元，年複合成長率為14.4%。

圖 1. 2023 年全球真實世界資料(RWD)市場佔有率(%)（按地區）

真實世界資料（RWD）在理解和解決各個領域的複雜挑戰方面發揮關鍵作用。這是指從現實世界情況收集的資訊，例如人口統計、經濟指標、醫療記錄和環境因素。與模擬和理論資料不同，世界各地的真實資料(RWD) 提供對真實事件、行為和趨勢的洞察。這使得研究人員、政策制定者和企業能夠做出資訊的決策、開發準確的模型並實施有效的策略。隨著先進技術的出現和大規模資料的可用性不斷增加，全球真實世界資料(RWD) 分析在發現模式、識別相關性和生成可操作知識方面變得越來越有價值。我們推動創新並改善各種結果地區。真實世界資料市場是指傳統臨床試驗以外的各種來源的資料收集和分析。這些資訊來源包括電子健康記錄、保險申請資料、病患登記，甚至穿戴式裝置的資料。這些資料為醫療保健決策和策略提供資訊，改善患者治療結果，並推動醫療保健行業的創新。

市場動態：

預計市場上新產品推出的增加將推動預測期內的市場成長。例如，2022 年 11 月，分散和混合臨床試驗技術解決方案的領先供應商 Castor 宣布推出新產品，以簡化上市後臨床試驗。透過擴大全球覆蓋範圍、整合真實世界資料(RWD) 以及自動化臨床試驗流程，Castor 的最新服務可以將臨床試驗成本降低 30%，並將部署時間表平均縮短至僅四週。

然而，資料品質和完整性、資料隱私和監管合規性、資料碎片、互通性、選擇偏差和普遍性阻礙了預測期內全球真實世界資料（RWD）市場的成長。

本研究的主要特點

• 本報告對全球真實世界資料（RWD）市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023年至2030年）的市場規模和年複合成長率。
• 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
• 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球真實世界資料(RWD) 市場的主要企業。
• 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
• 本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球真實世界資料（RWD）市場的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

• 研究目標
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章 全球真實世界資料（RWD）市場－冠狀病毒（COVID-19）大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章 2018-2030 年全球真實世界資料(RWD) 市場（按組成部分）

• 服務
• 資料集
• 臨床設定資料
• 申請和申請資料
• 藥房資料
• 基於註冊表的資料
• 患者資料

第6章 全球真實世界資料(RWD) 市場（按應用），2018-2030 年

• 藥物研發及核准
• 市場進入和報銷/覆蓋範圍確定
• 上市後監測
• 臨床研究
• 其他用途

第7章 全球真實世界資料(RWD) 市場，按最終用戶分類，2018-2030 年

• 醫療保健公司
• 醫療服務提供方
• 政府機關
• 其他

第8章 全球真實世界資料(RWD) 市場，按地區分類，2018-2030 年

• 北美洲
• 美國
• 加拿大
• 歐洲
• 德國
• 英國
• 西班牙
• 法國
• 義大利
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• ASEAN
• 其他亞太地區
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 北非
• 南非
• 中部非洲

第9章 競爭形勢

• IQVIA Holdings Inc.
• Optum, Inc.（a subsidiary of UnitedHealth Group）
• Centre Corporation
• Flatiron Health, Inc.
• IBM Corporation
• Tempus Labs Inc.
• Syneos Health Inc.
• Evidera, Inc.
• Palantir Technologies Inc.
• SAS Institute Inc.

第10章 章

• 調查方法
• 關於出版商

The global real world data (RWD) market size is projected to grow from US$ 1.59 Bn in 2023 to US$ 4.07 Bn by 2030, at a CAGR of 14.4%.

Figure 1. Global Real World Data (RWD) Market Share (%), By Region, 2023

Real world data plays a crucial role in understanding and addressing complex challenges across various fields. It refers to information gathered from real-life situations, such as demographics, economic indicators, healthcare records, environmental factors, and more. Unlike simulated or theoretical data, global real world data (RWD) offers insights into actual events, behaviours and trends. It enables researchers, policymakers and businesses to make informed decisions, develop accurate models, and implement effective strategies. With the advent of advanced technologies and the growing availability of large-scale data, global real world data (RWD) analysis has become increasingly valuable in uncovering patterns, identifying correlations, and generating actionable knowledge to drive innovation and improve outcomes in diverse domains. The real-world data market refers to the collection and analysis of data from various sources outside of traditional clinical trials. These sources can include electronic health records, insurance claims data, patient registries, and even data from wearable devices. This data is then used to inform healthcare decisions and strategies, improve patient outcomes, and drive innovation in the healthcare industry.

Market Dynamics:

The increasing introduction of new products in the market is expected to drive the growth of the market over the forecast period. For instance, in November 2022, Castor, a leading provider of decentralized and hybrid clinical trial technology solutions, announced a new offering to simplify post-marketing clinical trials. By extending global reach, integrating real-world data (RWD), and automating trial processes, Castor's latest offering can reduce trial costs by 30% and deployment timelines to only 4 weeks on average.

However, data quality and completeness, data privacy and regulatory compliance, data fragmentation, and interoperability and selection bias and generalizability are expected to hamper growth of the global real world data (RWD) market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global real world data (RWD) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global real world data (RWD) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include IQVIA Holdings Inc., Optum, Inc. (a subsidiary of UnitedHealth Group), Cerner Corporation, Flatiron Health, Inc., IBM Corporation, Tempus Labs Inc., Syneos Health Inc., Evidera, Inc., Palantir Technologies Inc., SAS Institute Inc.,
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The real world data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global real world data (RWD) market

Detailed Segmentation:

• By Component:
  • Services
  • Datasets
  • Clinical settings Data
  • Claims & Billing Data
  • Pharmacy Data
  • Registry-Based Data
  • Patient-Powered Data
• By Application:
  • Drug development and approvals
  • Market access and reimbursement/coverage decisions
  • Post-market surveillance
  • Clinical research
  • Other applications
• By End User:
  • Pharmaceutical and medical device Companies
  • Healthcare payers
  • Healthcare providers
  • Government agencies
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • IQVIA Holdings Inc.
  • Optum, Inc. (a subsidiary of UnitedHealth Group)
  • Cerner Corporation
  • Flatiron Health, Inc.
  • IBM Corporation
  • Tempus Labs Inc.
  • Syneos Health Inc.
  • Evidera, Inc.
  • Palantir Technologies Inc.
  • SAS Institute Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Global Real World Data (RWD) , By Component
  • Market Global Real World Data (RWD), By Application
  • Market Global Real World Data (RWD), By End user
  • Market Global Real World Data (RWD), By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Real World Data (RWD) Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Real World Data (RWD) Market , By Component, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2018 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Datasets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Clinical settings Data
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Claims & Billing Data
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Pharmacy Data
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Registry-Based Data
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Patient-Powered Data
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Real World Data (RWD) Market , By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2018 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Drug development and approvals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Market access and reimbursement/coverage decisions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Post-market surveillance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Clinical research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Other applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Real World Data (RWD) Market , By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2018 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
  • Pharmaceutical and medical device Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Healthcare prayers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Healthcare providers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Government agencies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Real World Data (RWD) Market , By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2018 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
• North Africa
• South Africa
• Central Africa

9. Competitive Landscape

• IQVIA Holdings Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Optum, Inc. (a subsidiary of UnitedHealth Group)
• Centre Corporation
• Flatiron Health, Inc.
• IBM Corporation
• Tempus Labs Inc.
• Syneos Health Inc.
• Evidera, Inc.
• Palantir Technologies Inc.
• SAS Institute Inc.
• Analyst Views

10. Section

• Research Methodology
• About us